论文部分内容阅读
目的通过应用依达拉奉治疗急性脑梗死,观察其治疗效果。方法选择2007年1月至2009年12月本院神经内科收住院符合入选标准的78例急性脑梗死患者。随机分为观察组40例,对照组38例。观察组在给予治疗急性脑梗死的基础方案上加用依达拉奉药物,对照组给予脑梗死基础治疗方案。两组均治疗14 d为一疗程。结果观察组基本痊愈11例,显效13例,进步10例,无进步5例,恶化1例,总有效率为85.0%;对照组基本痊愈5例,显效7例,进步12例,无进步13例,恶化1例,总有效率63.1%。结论急性期脑梗死患者在给予常规基础方案治疗上加用依达拉奉药物效果优于常规基础治疗方案。
Objective To observe the therapeutic effect of Edaravone on acute cerebral infarction. Methods From January 2007 to December 2009, 78 patients with acute cerebral infarction admitted to our department of neurology admitted to our hospital were enrolled. Randomly divided into observation group 40 cases, control group 38 cases. The observation group was treated with edaravone on the basis of the basic plan for the treatment of acute cerebral infarction, while the control group was given basic treatment of cerebral infarction. Both groups were treated for 14 days for a course of treatment. Results The observation group basically recovered in 11 cases, markedly improved in 13 cases, improved in 10 cases, no progress in 5 cases, worsening in 1 case, the total effective rate was 85.0%; control group basically recovered in 5 cases, markedly effective in 7 cases, improved in 12 cases, no progress 13 In one case, one case of deterioration, the total effective rate 63.1%. Conclusion Patients with acute cerebral infarction in the treatment of conventional basic programs plus edaravone drugs better than the conventional basic treatment.